203 related articles for article (PubMed ID: 7749499)
1. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a.
Preziati D; La Rosa L; Covini G; Marcelli R; Rescalli S; Persani L; Del Ninno E; Meroni PL; Colombo M; Beck-Peccoz P
Eur J Endocrinol; 1995 May; 132(5):587-93. PubMed ID: 7749499
[TBL] [Abstract][Full Text] [Related]
2. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.
Marazuela M; García-Buey L; González-Fernández B; García-Monzón C; Arranz A; Borque MJ; Moreno-Otero R
Clin Endocrinol (Oxf); 1996 Jun; 44(6):635-42. PubMed ID: 8759175
[TBL] [Abstract][Full Text] [Related]
3. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
Chung YH; Shong YK
Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
[TBL] [Abstract][Full Text] [Related]
4. Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study.
Mazziotti G; Sorvillo F; Stornaiuolo G; Rotondi M; Morisco F; Ruberto M; Cioffi M; Amato G; Caporaso N; Gaeta GB; Carella C
J Endocrinol Invest; 2002; 25(7):624-30. PubMed ID: 12150338
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.
Fernandez-Soto L; Gonzalez A; Escobar-Jimenez F; Vazquez R; Ocete E; Olea N; Salmeron J
Arch Intern Med; 1998 Jul; 158(13):1445-8. PubMed ID: 9665354
[TBL] [Abstract][Full Text] [Related]
6. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.
Custro N; Montalto G; Scafidi V; Soresi M; Gallo S; Tripi S; Notarbartolo A
J Endocrinol Invest; 1997; 20(7):374-80. PubMed ID: 9309534
[TBL] [Abstract][Full Text] [Related]
7. Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C.
Hsieh MC; Yu ML; Chuang WL; Shin SJ; Dai CY; Chen SC; Lin ZY; Hsieh MY; Liu JF; Wang LY; Chang WY
Eur J Endocrinol; 2000 May; 142(5):431-7. PubMed ID: 10802518
[TBL] [Abstract][Full Text] [Related]
8. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.
Roti E; Minelli R; Giuberti T; Marchelli S; Schianchi C; Gardini E; Salvi M; Fiaccadori F; Ugolotti G; Neri TM; Braverman LE
Am J Med; 1996 Nov; 101(5):482-7. PubMed ID: 8948271
[TBL] [Abstract][Full Text] [Related]
9. [Hepatitis C virus infection and thyroid diseases].
Broussolle C; Steineur MP; Bailly F; Zoulim F; Trépo C
Rev Med Interne; 1999 Sep; 20(9):766-73. PubMed ID: 10522298
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies during alpha-interferon therapy for chronic hepatitis B.
Fattovich G; Betterle C; Brollo L; Pedini B; Giustina G; Realdi G; Alberti A; Ruol A
J Med Virol; 1991 Jun; 34(2):132-5. PubMed ID: 1890413
[TBL] [Abstract][Full Text] [Related]
11. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
[TBL] [Abstract][Full Text] [Related]
12. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
14. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.
Rostaing L; Oksman F; Izopet J; Baron E; Cisterne JM; Hoff M; Abbal M; Durand D
Am J Nephrol; 1996; 16(6):478-83. PubMed ID: 8955758
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.
Carella C; Mazziotti G; Morisco F; Manganella G; Rotondi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
J Clin Endocrinol Metab; 2001 May; 86(5):1925-9. PubMed ID: 11344186
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
[TBL] [Abstract][Full Text] [Related]
17. Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection.
Indolfi G; Stagi S; Bartolini E; Salti R; de Martino M; Azzari C; Resti M
Clin Endocrinol (Oxf); 2008 Jan; 68(1):117-21. PubMed ID: 17692107
[TBL] [Abstract][Full Text] [Related]
18. Autoimmunity during alpha-interferon therapy for chronic hepatitis C.
Yoshikawa M; Sakamoto T; Mitoro A; Mochi T; Tsujii H; Koizumi M; Yoshiji H; Sakaguchi Y; Fukui H; Nakano H
Gastroenterol Jpn; 1993 May; 28 Suppl 5():109-14. PubMed ID: 8359620
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study.
Huang MJ; Tsai SL; Huang BY; Sheen IS; Yeh CT; Liaw YF
Clin Endocrinol (Oxf); 1999 Apr; 50(4):503-9. PubMed ID: 10468911
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
